<VariationArchive VariationID="1456883" VariationName="NM_000263.4(NAGLU):c.642dup (p.Pro215fs)" VariationType="Duplication" Accession="VCV001456883" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1454985" VariationID="1456883">
      <GeneList>
        <Gene Symbol="NAGLU" FullName="N-acetyl-alpha-glucosaminidase" GeneID="4669" HGNC_ID="HGNC:7632" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="42536241" stop="42544449" display_start="42536241" display_stop="42544449" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="40687950" stop="40696466" display_start="40687950" display_stop="40696466" Strand="+" />
          </Location>
          <OMIM>609701</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000263.4(NAGLU):c.642dup (p.Pro215fs)</Name>
      <CanonicalSPDI>NC_000017.11:42538448:G:GG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q21.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="42538448" stop="42538449" display_start="42538448" display_stop="42538449" variantLength="1" positionVCF="42538448" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="40690466" stop="40690467" display_start="40690466" display_stop="40690467" variantLength="1" positionVCF="40690466" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>P215fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.40690467dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.40690467dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.42538449dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.42538449dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011552.1" sequenceAccession="NG_011552" sequenceVersion="1" change="g.7517dup">
            <Expression>NG_011552.1:g.7517dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000263.4" sequenceAccession="NM_000263" sequenceVersion="4" change="c.642dup" MANESelect="true">
            <Expression>NM_000263.4:c.642dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000254.2" sequenceAccession="NP_000254" sequenceVersion="2" change="p.Pro215fs">
            <Expression>NP_000254.2:p.Pro215fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2092912932" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000263.4(NAGLU):c.642dup (p.Pro215fs) AND multiple conditions" Accession="RCV001953487" Version="3">
        <ClassifiedConditionList TraitSetID="23227">
          <ClassifiedCondition DB="MedGen" ID="C5569050">Charcot-Marie-Tooth disease axonal type 2V</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0086648">Mucopolysaccharidosis, MPS-III-B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10094189</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16151907</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9832037</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="23227" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3221" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Mucopoly-saccharidosis type 3B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sanfilippo syndrome B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">N-acetyl-alpha-d-glucosaminidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS 3B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">NAGLU DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="252920" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Mucopolysaccharidosis, MPS-III-B</ElementValue>
                <XRef ID="Mucopolysaccharidosis+type+IIIB/4916" DB="Genetic Alliance" />
                <XRef ID="59990008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUCOPOLYSACCHARIDOSIS, TYPE IIIB</ElementValue>
                <XRef Type="MIM" ID="252920" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="609701.0012" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MPS III B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucopolysaccharidosis type IIIB (Sanfilippo B)</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MPS3B</ElementValue>
                <XRef Type="MIM" ID="252920" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Mucopolysaccharidosis type III (MPS III) is a multisystem lysosomal storage disease characterized by progressive central nervous system degeneration manifest as severe intellectual disability (ID), developmental regression, and other neurologic manifestations including autism spectrum disorder (ASD), behavioral problems, and sleep disturbances. Disease onset is typically before age ten years. Disease course may be rapidly or slowly progressive; some individuals with an extremely attenuated disease course present in mid-to-late adulthood with early-onset dementia with or without a history of ID. Systemic manifestations can include musculoskeletal problems (joint stiffness, contractures, scoliosis, and hip dysplasia), hearing loss, respiratory tract and sinopulmonary infections, and cardiac disease (valvular thickening, defects in the cardiac conduction system). Neurologic decline is seen in all affected individuals; however, clinical severity varies within and among the four MPS III subtypes (defined by the enzyme involved) and even among members of the same family. Death usually occurs in the second or third decade of life secondary to neurologic regression or respiratory tract infections.</Attribute>
                <XRef ID="NBK546574" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7072" />
                <XRef ID="7072" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536183</ID>
                <ID Source="BookShelf">NBK546574</ID>
              </Citation>
              <XRef ID="79270" DB="Orphanet" />
              <XRef ID="C0086648" DB="MedGen" />
              <XRef ID="MONDO:0009656" DB="MONDO" />
              <XRef Type="MIM" ID="252920" DB="OMIM" />
            </Trait>
            <Trait ID="33609" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 2V</ElementValue>
                <XRef Type="MIM" ID="616491" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL DOMINANT, TYPE 2V</ElementValue>
                <XRef Type="MIM" ID="616491" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease axonal type 2V</ElementValue>
                <XRef ID="MONDO:0014665" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMT2V</ElementValue>
                <XRef Type="MIM" ID="616491" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17777" />
                <XRef ID="17777" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="447964" DB="Orphanet" />
              <XRef ID="C5569050" DB="MedGen" />
              <XRef ID="MONDO:0014665" DB="MONDO" />
              <XRef Type="MIM" ID="616491" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4263227" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="6503194|MedGen:C4225306;C0086648" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002241293" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9832037</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10094189</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16151907</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro215Alafs*58) in the NAGLU gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NAGLU are known to be pathogenic (PMID: 9832037, 10094189, 16151907). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with NAGLU-related conditions. This variant is not present in population databases (ExAC no frequency).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAGLU" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.40690466_40690467insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4225306" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0086648" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4263227" TraitType="Disease" MappingType="XRef" MappingValue="C4225306" MappingRef="MedGen">
        <MedGen CUI="C5569050" Name="Charcot-Marie-Tooth disease axonal type 2V" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4263227" TraitType="Disease" MappingType="XRef" MappingValue="C0086648" MappingRef="MedGen">
        <MedGen CUI="C0086648" Name="Mucopolysaccharidosis, MPS-III-B" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

